Real Business - The Champion of UK Enterprise

IS Pharma goes for growth

By Real Deals, published 2 years ago in Finance & Banking.

Chester-based medical devices business gets a major boost.

Share

Bank of Scotland Corporate is to provide AIM-listed IS Pharma with a facility worth £8m (€10m) to fund the company’s continued growth and acquisition plans.

IS Pharma is a late-stage pharmaceuticals and medical devices business in the specialist hospital medicine sector, with a current focus on critical care, neurology and oncology.

The Chester-based company recently acquired Swiss pharmaceuticals group, Speciality European Pharmaceuticals, for £9.25m.

IS Pharma, previously Maelor, adopted its new name following the acquisition, which has given it a new portfolio of specialist hospital pharmaceutical products.

Share

| More

0 comments.

There are currently no comments. Be the first...

Leave a Comment

Please complete all the fields below and hit post. Remember, no link dropping or spam please!

Comments are moderated and may not be published immediately.

Editor's Comment

Matthew Rock

By Matthew Rock.

I met the man who taught Britain to rock n' roll.... Read this comment in full »

Read all comments »